- Home
- HSTM vs CSTL Comparison
HSTM vs CSTL Comparison
Compare HSTM & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- CSTL
- Stock Information
- Founded
- HSTM 1990
- CSTL 2007
- Country
- HSTM United States
- CSTL United States
- Employees
- HSTM N/A
- CSTL N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- CSTL Medical Specialities
- Sector
- HSTM Technology
- CSTL Health Care
- Exchange
- HSTM Nasdaq
- CSTL Nasdaq
- Market Cap
- HSTM 892.1M
- CSTL 946.1M
- IPO Year
- HSTM 2000
- CSTL 2019
- Fundamental
- Price
- HSTM $31.63
- CSTL $28.56
- Analyst Decision
- HSTM Hold
- CSTL Strong Buy
- Analyst Count
- HSTM 2
- CSTL 7
- Target Price
- HSTM $29.00
- CSTL $37.57
- AVG Volume (30 Days)
- HSTM 147.2K
- CSTL 451.3K
- Earning Date
- HSTM 10-21-2024
- CSTL 11-04-2024
- Dividend Yield
- HSTM 0.36%
- CSTL N/A
- EPS Growth
- HSTM 52.12
- CSTL N/A
- EPS
- HSTM 0.65
- CSTL 0.21
- Revenue
- HSTM $287,992,000.00
- CSTL $311,878,000.00
- Revenue This Year
- HSTM $6.35
- CSTL $49.05
- Revenue Next Year
- HSTM $5.23
- CSTL N/A
- P/E Ratio
- HSTM $48.51
- CSTL $137.24
- Revenue Growth
- HSTM 3.96
- CSTL 62.43
- 52 Week Low
- HSTM $23.92
- CSTL $16.97
- 52 Week High
- HSTM $32.93
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- HSTM 56.66
- CSTL 38.37
- Support Level
- HSTM $31.20
- CSTL $27.24
- Resistance Level
- HSTM $32.27
- CSTL $29.02
- Average True Range (ATR)
- HSTM 0.67
- CSTL 1.89
- MACD
- HSTM -0.04
- CSTL -0.63
- Stochastic Oscillator
- HSTM 61.58
- CSTL 13.95
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.